<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00815490</url>
  </required_header>
  <id_info>
    <org_study_id>Pro00002400</org_study_id>
    <nct_id>NCT00815490</nct_id>
  </id_info>
  <brief_title>Validation of Brain Oxygenation Monitor</brief_title>
  <official_title>Calibration and Validation of the Nonin Non-invasive Cerebral Oxygen Saturation Oximeter and Cerebral Sensor in Human Volunteers</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Duke University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Nonin Medical, Inc</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Duke University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A cerebral oximeter is a device that uses light to measure the amount of oxygen within the
      brain. It is similar to the device that measures the level of oxygen in the tip of the
      finger, known as a pulse oximeter. The cerebral oximeter consists of a sensor placed on the
      forehead that both emits and detects the amount of light absorbed. This study will determine
      how accurate the device is by comparing the displayed value on the monitor with blood samples
      taken simultaneously from the arterial blood in the wrist and venous blood in the neck. In
      order to test the device over a suitable range, the level of oxygen within the blood will be
      reduced in a controlled manner by reduction of the inspired oxygen concentration. This is the
      equivalent of ascending to an altitude of 16,000 feet. The study will be conducted in healthy
      volunteers.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a calibration and validation study of a near-infrared spectroscopy (NIRS) device
      designed to measure the cerebral tissue oxygen saturation non-invasively. This is achieved by
      comparing NIRS-derived cerebral tissue oxygen saturation with a calculated value derived from
      simultaneous arterial and jugular venous blood samples.

      At present the FDA have adopted the standards published in 2005 by the International
      Organization for Standardization (ISO), entitled ISO 9919. This is a set of technical
      specifications and guidelines for pulse oximeters, which share certain technical similarities
      to cerebral oximeters. In particular, Annex EE details the conduct of a controlled
      desaturation study for the calibration of pulse oximeter equipment. Specifically, the
      fraction of inspired oxygen delivered to test subjects is varied to achieve a series of
      targeted steady state saturation periods over a range of arterial oxygen saturation of 70 -
      100%.

      While cerebral oximeters differ from pulse oximeters in terms of the what is being measured
      (brain tissue v arterial blood) the FDA have maintained the requirement to examine data from
      human volunteer studies in which the arterial oxygen saturation ranges from 70 - 100%. Two
      FDA-approved cerebral oximeters were validated in a similar manner.

      The device controlling the inspired gas concentration is the RespirAct, which permits precise
      reduction in the arterial oxygen saturation while maintaining the arterial carbon dioxide
      level at 40 mmHg.

      The study consists of 3 sequences:

        -  First sequence: reduction in arterial oxygen saturation in approximately 5% increments
           from 100 to 70% followed by return to room air and then a period of supplemental oxygen.

        -  Second sequence: reduction in arterial oxygen saturation in a single drop from 100 to
           70% followed by return to room air and then a period of supplemental oxygen.

        -  Third sequence: reduction in arterial oxygen saturation in approximately 10% increments
           from 100 to 70% with alteration of carbon dioxide level from 35 to 45 mmHg at each
           interval followed by return to room air.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2008</start_date>
  <completion_date type="Actual">April 2012</completion_date>
  <primary_completion_date type="Actual">November 2008</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Accuracy of Sensor</measure>
    <time_frame>Data collected from individual participants over 1 hour timeframe. Data from cohort of subjects collected over 6 month period.</time_frame>
    <description>A scatterplot is created with the forehead sensor saturation on the y-axis and the measured blood saturation on the x-axis. The line of identity is drawn representing the ideal points, meaning that the forehead sensor saturation is always the same as the blood saturation. The dispersion of the actual data points around this line of identity can be measured using a statistical calculation called Arithmetic Root Mean Square or ARMS. The smaller the ARMS the closer the data points lie around the line of identity, representing a more accurate sensor.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">18</enrollment>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>Desaturation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Human volunteers undergo oxygen desaturation in order to determine the accuracy of the device over a clinical range of oxygen saturations 70 - 100%.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Desaturation</intervention_name>
    <description>Reduction in blood oxygen saturation by sequential reduction in inspired gas composition. Steps are of 6 minutes duration with reduction in pulse oximeter oxygen saturation from 100 to 70%.</description>
    <arm_group_label>Desaturation</arm_group_label>
    <other_name>Nonin cerebral oximeter</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  21 to 35 years

          -  American Society of Anesthesiologists health assessment level 1

          -  Body Mass Index (BMI) 18 to 30

        Exclusion Criteria:

          -  anemia

          -  hemoglobinopathy (e.g. sickle cell disease, thalassemia)

          -  positive pregnancy test (females)

          -  significant cardiac or pulmonary disease

          -  history of sleep apnea

          -  tobacco, drug or alcohol abuse

          -  difficult airway

          -  abnormal EKG / pulmonary function test / room air saturation

          -  intolerance to breathing mask apparatus
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>David B MacLeod, FRCA</last_name>
    <role>Principal Investigator</role>
    <affiliation>Duke University Health System</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Duke University Health System</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27705</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>MacLeod DB, Ikeda K, Vacchiano C, Lobbestael A, Wahr JA, Shaw AD. Development and validation of a cerebral oximeter capable of absolute accuracy. J Cardiothorac Vasc Anesth. 2012 Dec;26(6):1007-14. doi: 10.1053/j.jvca.2012.06.010. Epub 2012 Aug 9.</citation>
    <PMID>22883447</PMID>
  </results_reference>
  <verification_date>March 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 26, 2008</study_first_submitted>
  <study_first_submitted_qc>December 29, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 30, 2008</study_first_posted>
  <results_first_submitted>November 19, 2012</results_first_submitted>
  <results_first_submitted_qc>March 6, 2013</results_first_submitted_qc>
  <results_first_posted type="Estimate">April 16, 2013</results_first_posted>
  <last_update_submitted>March 6, 2013</last_update_submitted>
  <last_update_submitted_qc>March 6, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 16, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Duke University</investigator_affiliation>
    <investigator_full_name>David MacLeod</investigator_full_name>
    <investigator_title>Assistant Clinical professor</investigator_title>
  </responsible_party>
  <keyword>Spectroscopy, near infrared</keyword>
  <keyword>Oximetry</keyword>
  <keyword>Hypoxemia</keyword>
  <keyword>Tissue oxygenation</keyword>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Recruitment 10/2007 - 12/2008 at Duke University Medical Center.</recruitment_details>
      <pre_assignment_details>Healthy volunteers recruited with specific exclusion of anemia &amp; hemoglobinopathy.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Calibration</title>
          <description>Initial group of subjects on whom the test algorithm is developed.</description>
        </group>
        <group group_id="P2">
          <title>Validation</title>
          <description>Group of subjects in whom the final algorithm is tested.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="9"/>
                <participants group_id="P2" count="9"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="9"/>
                <participants group_id="P2" count="9"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Calibration</title>
          <description>Initial group of subjects on whom the test algorithm is developed.</description>
        </group>
        <group group_id="B2">
          <title>Validation</title>
          <description>Group of subjects in whom the final algorithm is tested.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="9"/>
            <count group_id="B2" value="9"/>
            <count group_id="B3" value="18"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <description>Age</description>
          <units>Years</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="25" lower_limit="21" upper_limit="31"/>
                    <measurement group_id="B2" value="26" lower_limit="21" upper_limit="34"/>
                    <measurement group_id="B3" value="25.7" lower_limit="21" upper_limit="34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>Participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race/Ethnicity, Customized</title>
          <units>Participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Hispanic</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>African American</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Caucasian</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Asian</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Accuracy of Sensor</title>
        <description>A scatterplot is created with the forehead sensor saturation on the y-axis and the measured blood saturation on the x-axis. The line of identity is drawn representing the ideal points, meaning that the forehead sensor saturation is always the same as the blood saturation. The dispersion of the actual data points around this line of identity can be measured using a statistical calculation called Arithmetic Root Mean Square or ARMS. The smaller the ARMS the closer the data points lie around the line of identity, representing a more accurate sensor.</description>
        <time_frame>Data collected from individual participants over 1 hour timeframe. Data from cohort of subjects collected over 6 month period.</time_frame>
        <population>Multiple data points from each individual were pooled and presented as group data.</population>
        <group_list>
          <group group_id="O1">
            <title>Calibration</title>
            <description>Initial group of subjects on whom the test algorithm is developed.</description>
          </group>
          <group group_id="O2">
            <title>Validation</title>
            <description>Group of subjects in whom the final algorithm is tested.</description>
          </group>
        </group_list>
        <measure>
          <title>Accuracy of Sensor</title>
          <description>A scatterplot is created with the forehead sensor saturation on the y-axis and the measured blood saturation on the x-axis. The line of identity is drawn representing the ideal points, meaning that the forehead sensor saturation is always the same as the blood saturation. The dispersion of the actual data points around this line of identity can be measured using a statistical calculation called Arithmetic Root Mean Square or ARMS. The smaller the ARMS the closer the data points lie around the line of identity, representing a more accurate sensor.</description>
          <population>Multiple data points from each individual were pooled and presented as group data.</population>
          <units>percentage saturation</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="9"/>
                <count group_id="O2" value="9"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.0" lower_limit="2.6" upper_limit="3.5"/>
                    <measurement group_id="O2" value="8.1" lower_limit="7.0" upper_limit="9.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Calibration</title>
          <description>Initial group of subjects on whom the test algorithm is developed.</description>
        </group>
        <group group_id="E2">
          <title>Validation</title>
          <description>Group of subjects in whom the final algorithm is tested.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr David MacLeod</name_or_title>
      <organization>Duke University Medical Center</organization>
      <phone>919-812-3201</phone>
      <email>david.macleod@duke.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

